Weiss Multi Strategy Advisers LLC Intercept Pharmaceuticals, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$39.09 - $53.44 $404,698 - $553,264	-10,353 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $16,485 - $32,490	353 Added 3.53%	10,353 $496,000
Q4 2019 Feb 14, 2020	SELL	$57.36 - $124.1 $229,440 - $496,400	-4,000 Reduced 28.57%	10,000 $1.24 Million
Q3 2019 Nov 14, 2019	BUY	$58.69 - $80.46 $58,690 - $80,460	1,000 Added 7.69%	14,000 $929,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $388,850 - $603,400	5,000 Added 62.5%	13,000 $1.03 Million
Q1 2019 May 15, 2019	BUY	$91.83 - $120.68 $734,640 - $965,440	8,000 New	8,000 $895,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.